Picture 1 of 1
Lipid A in Cancer Therapy by Jean-Francois Jeannin (English) Hardcover Book
Condition:
Shipping:
Located in: Fairfield, Ohio, United States
Delivery:
Estimated between Thu, Jun 27 and Tue, Jul 9 to 43230
Returns:
Payments:
Shop with confidence
Seller information
- 98.3% positive feedback
Registered as a Business Seller
Seller assumes all responsibility for this listing.
eBay item number:364800573825
Item specifics
- Condition
- ISBN-13
- 9781441916020
- Book Title
- Lipid A in Cancer Therapy
- ISBN
- 9781441916020
- Subject Area
- Science, Medical
- Publication Name
- Lipid a in Cancer Therapy
- Publisher
- Springer New York
- Item Length
- 9.3 in
- Subject
- Life Sciences / Cell Biology, Oncology, Research
- Publication Year
- 2009
- Series
- Advances in Experimental Medicine and Biology Ser.
- Type
- Textbook
- Format
- Hardcover
- Language
- English
- Item Weight
- 12.7 Oz
- Item Width
- 6.1 in
- Number of Pages
- 152 Pages
About this product
Product Information
Cancer remains a major challenge for modern society. Not only does cancer rank among the first three causes of mortality in most population groups but also the therapeutic options available for most tumor types are limited. The existing ones have limited efficacy, lack specificity and their administration carry major side effects. Hence the urgent need for novel cancer therapies. One of the most promising avenues in research is the use of specific immunotherapy. The notion that the immune system may have important anti-tumor effects has been around for more than a century now. Every major progress in microbiology and immunology has been immediately followed by attempts to apply the new knowledge to the treatment of cancer. Progress has reached a point where it is well established that most cancer patients mount specific T cell responses against their tumors. The molecular identity of the antigens recognized by anti-tumor T cells has been elucidated and several hundreds of tumor-derived antigenic peptides have been discovered. Upon recognition of such peptides presented by self MHC molecules, both CD8 and CD4 T cells are activated, expand to high numbers and differentiate into effective anti-tumor agents. CD8 T cells directly destroy tumor cells and can cause even large tumors to completely regress in experimental mouse models. These observations have spurred intense research activity aimed at designing and testing cancer vaccines. Over 100 years ago Coley successfully used intratumoral injection of killed bacteria to treat sarcomas. The important anti-tumor effects observed in a fraction of these patients fueled major research efforts. These led to major discoveries in the 80s and the 90s. It turns out that bacterial lipopolysaccharides stimulate the production of massive amounts of a cytokine still known today as tumor necrosis factor (TNF-a). They do so by engagement of a rather complex set of interactions culminating in the ligation of a Toll-like receptor, TLR -4. Ensuing signaling through this receptor initiates potent innate immune responses. Unfortunately the clinical use of both TNF-a and LPS can not be generalized due to their very narrow therapeutic margin. Importantly, synthetic Lipid A analogs have been identified that retain useful bioactivity and yet possess only mild toxicity. The relatively large body of information accumulated thus far on the molecular and cellular interactions set in motion by administration of LPS as well as by the synthetic lipid A analogs allow to place this family of bacterially-derived molecules at the crossroads between innate and adaptive immunity. By virtue of this key position, the therapeutic applications being pursued aim at using these compounds either as direct anti-tumor agents or as vaccine adjuvants. The clinical experience acquired so far on these two avenues is asymmetric. Few clinical trials using Lipid A analogs as single anti-cancer agents involving less than 100 patients with advanced cancer have been reported. In contrast, lipid A has been tested in over 300,000 individuals in various vaccines trials, including therapeutic cancer vaccines. Clearly most of the work needed to develop lipid A as effective anti-cancer agents and/or as vaccine adjuvant lies ahead in the near future. This book is a timely contribution and provides a much needed up-to-date overview of the chemical, biological and physiological aspects of lipid A. It should be a beacon to all those involved in this field of research.
Product Identifiers
Publisher
Springer New York
ISBN-10
1441916024
ISBN-13
9781441916020
eBay Product ID (ePID)
78710177
Product Key Features
Number of Pages
152 Pages
Language
English
Publication Name
Lipid a in Cancer Therapy
Publication Year
2009
Subject
Life Sciences / Cell Biology, Oncology, Research
Type
Textbook
Subject Area
Science, Medical
Series
Advances in Experimental Medicine and Biology Ser.
Format
Hardcover
Dimensions
Item Weight
12.7 Oz
Item Length
9.3 in
Item Width
6.1 in
Additional Product Features
Intended Audience
Scholarly & Professional
LCCN
2009-035583
Dewey Edition
22
Series Volume Number
667
Number of Volumes
1 Vol.
Illustrated
Yes
Dewey Decimal
616.99/4061
Lc Classification Number
R850.A1-854
Table of Content
Introduction: Historical Background.- Structure andSynthesis of Lipid A.- Conformation and Supramolecular Structure of Lipid A.- Interactions between Lipid A and Serum Proteins.- The Lipid A Receptor.- Lipid A Receptor TLR4-Mediated Signaling Pathways.- Lipid A-Induced Responses In Vivo.- Lipid A-Mediated Tolerance and Cancer Therapy.- Lipid A in Cancer Therapies Preclinical Results.- Monophosphoryl Lipid A (MPL) as an Adjuvant for Anti-Cancer Vaccines: Clinical Results.- Antitumoral Effects of Lipids A, Clinical Studies.- Conclusion.
Copyright Date
2010
Item description from the seller
Seller assumes all responsibility for this listing.
eBay item number:364800573825
Shipping and handling
Item location:
Fairfield, Ohio, United States
Ships to:
Afghanistan, Albania, Algeria, Andorra, Angola, Anguilla, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan Republic, Bahamas, Bahrain, Bangladesh, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, British Virgin Islands, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde Islands, Cayman Islands, Central African Republic, Chad, Chile, China, Colombia, Comoros, Cook Islands, Costa Rica, Cyprus, Czech Republic, Côte d'Ivoire (Ivory Coast), Democratic Republic of the Congo, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Falkland Islands (Islas Malvinas), Fiji, Finland, France, Gabon Republic, Gambia, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guatemala, Guernsey, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jersey, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Liechtenstein, Lithuania, Luxembourg, Macau, Macedonia, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Mauritania, Mauritius, Mayotte, Mexico, Moldova, Monaco, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Namibia, Nauru, Nepal, Netherlands, Netherlands Antilles, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norway, Oman, Pakistan, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Republic of Croatia, Republic of the Congo, Romania, Rwanda, Saint Helena, Saint Kitts-Nevis, Saint Lucia, Saint Pierre and Miquelon, Saint Vincent and the Grenadines, San Marino, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Korea, Spain, Sri Lanka, Suriname, Svalbard and Jan Mayen, Swaziland, Sweden, Switzerland, Taiwan, Tajikistan, Tanzania, Thailand, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Turks and Caicos Islands, Tuvalu, Uganda, United Arab Emirates, United Kingdom, Uruguay, Uzbekistan, Vanuatu, Vatican City State, Vietnam, Wallis and Futuna, Western Sahara, Worldwide, Yemen, Zambia, Zimbabwe
Excludes:
APO/FPO, Alaska/Hawaii, Barbados, Belarus, French Guiana, French Polynesia, Guadeloupe, Libya, Martinique, New Caledonia, Panama, Papua New Guinea, Reunion, Russian Federation, US Protectorates, Ukraine, Venezuela, Western Samoa
| Shipping and handling | To | Service | Delivery*See Delivery notes |
|---|---|---|---|
| Free shipping | United States | Economy Shipping | Estimated between Thu, Jun 27 and Tue, Jul 9 to 43230 |
| Handling time |
|---|
| Will usually ship within 3 business days of receiving cleared payment. |
| Taxes |
|---|
| Taxes may be applicable at checkout. Learn moreLearn more about paying tax on eBay purchases |
Sales tax for an item #364800573825
Sales tax for an item #364800573825
Seller collects sales tax for items shipped to the following provinces:
| Province | Sales Tax Rate |
|---|
Return policy
| After receiving the item, contact seller within | Refund will be given as |
|---|---|
| 30 days after the buyer receives it | Money Back |
The buyer is responsible for return shipping costs.
Payment details
Payment methods
Seller feedback (1,025,523)
i***6 (139)- Feedback left by buyer.
Past 6 months
Verified purchase
Item as described, good price, well packaged, arrived slightly later than hoped (not in time for Christmas ) but the order was placed in a very busy shipping period. No issue with the seller’s speed of response and sending the item. Great seller!
l***a (3517)- Feedback left by buyer.
Past month
Verified purchase
Excellent seller. Timely shipping, safe packing, good communication, great price and as described. Thank you. A+++
o***b (144)- Feedback left by buyer.
Past month
Verified purchase
The seller is one of the best there is - high quality books, reasonable prices, securely packaged.
I do, however, recommend some changes to their shipping - they show a shipper (SortHub) on eBay, but the tracking # they email is for a different carrier. It’s difficult to know where my purchase is.
This time, it was delivered a week late. In the grand scheme of things not a big deal. But it shouldn’t be this difficult to accurately track my purchase.
Product ratings and reviews
More to explore:
- Hardcovers Books in English,
- Hardcover Nonfiction Books in English,
- Nonfiction Books in English Fiction & Therapy,
- Fiction Hardcover Jean Craighead George & Books in English,
- Fiction Hardcover Books in English,
- Hardcover Antiquarian & Collectible Books in English,
- Hardcover Nonfiction Books in English Illustrated,
- Hardcover Books with Dust Jacket in English,
- Stephen King Hardcover Books in English,
- Young Adults Hardcover Books in English